argenx SE (ARGX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Presentation Richard VosserJPMorgan Chase & Co, Research Division Welcome to the first day of the 44th JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan. It's my great pleasure to introduce argenx CEO, Timothy Van Hauwermeiren. Just a few housekeeping rules. We will take questions from the room after Tim's presentation and/or you can submit those into the portal. So with that, Tim, welcome to the conference. Tim Van HauwermeirenCo-Founder, CEO & Executive Director Th ...